Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Stem Cell Research

Free Subscription Articles published in Leuk Lymphoma Retrieve available abstracts of 62 articles: HTML format Text format

Single Articles

January 2012
1. BEITINJANEH AM , Saliba R, Bashir Q, Shah N, et al
   Durable Responses after Donor Lymphocyte Infusion for Patients with Residual Multiple Myeloma following Non-myeloablative Allogeneic Stem Cell Transplantation.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. SIMARA P , Peterkova M, Stejskal S, Potesilova M, et al
   BCR-ABL activity measured by the IC50(imatinib), p-CrkL/CrkL ratio, or p-CrkL ratio in CD34+ cells of chronic myeloid leukemia patients does not predict treatment response.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
3. CAMPBELL P , Friebe A, Foulstone P, Grigg A, et al
   Impact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan-melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma.
   Leuk Lymphoma. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
4. TELIO D , Fernandes K, Ma C, Tsang R, et al
   Salvage Chemotherapy and Autologous Stem Cell Transplantation in Primary Refractory DLBCL: Outcomes and Prognostic Factors.
   Leuk Lymphoma. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. GOLDBERG JD , Chou JF, Horwitz S, Teruya-Feldstein J, et al
   Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplantation.
   Leuk Lymphoma. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. ANDERLINI P , Saliba R, Acholonu S, Okoroji GJ, et al
   Donor leukocyte infusions (DLIs) in recurrent hodgkin lymphoma (HL) following allogeneic stem cell transplantation: ten-year experience at the M.D. anderson cancer center.
   Leuk Lymphoma. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
7. LANE AA , Armand P, Feng Y, Neuberg DS, et al
   Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU, and etoposide (CBV) followed by autologous stem cell transplant.
   Leuk Lymphoma. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
8. ALIMOHAMED N , Daly A, Owen C, Duggan P, et al
   Thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary cns lymphoma: a single centre experience.
   Leuk Lymphoma. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. BAN-HOEFEN M , Kelly JL, Bernstein SH, Liesveld J, et al
   High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era.
   Leuk Lymphoma. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. EOM KS , Kim HJ, Cho BS, Choi SM, et al
    Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
11. WANG HX , Yan HM, Wang ZD, Xue M, et al
    Haploidentical hematopoietic stem cell transplantation in hematologic malignancies with G-CSF mobilized bone marrow plus peripheral blood stem cells grafts without T cell depletion: a single center report of 29 cases.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. SHAFEY M , Duan Q, Russell J, Duggan P, et al
    Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory hodgkin lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GRINBERG I , Dukhovny A, Goldstein RS
    A rapid and simple assay for human blood malignancy engraftment, homing and chemotherapy treatment using fluorescent imaging of avian embryos.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
14. ANDRESEN S , Brandt J, Dietrich S, Memmer ML, et al
    The Impact of High- Dose Chemotherapy, Autologous Stem Cell Transplantation and Conventional Chemotherapy on Quality of life of Long Term Survivors with Follicular Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. LAZAREVIC V , Remberger M, Hagglund H, Juliusson G, et al
    Long-term survival after allogeneic stem cell transplantation for relapsed large B cell lymphomas - A retrospective study.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
16. ANDERLINI P , Saliba RM, Ledesma C, Chancoco C, et al
    Gemcitabine, fludarabine and melphalan (G-FM) as a reduced-intensity conditioning regimen for allogeneic stem cell transplantation in relapsed and refractory hodgkin lymphoma: preliminary results.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
17. NISHIWAKI S , Miyamura K
    Allogeneic Stem Cell Transplantation For Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. WICKREMA A
    Will cord blood stem cells come to the rescue of keratinocyte growth factor?
    Leuk Lymphoma. 2011;52:1423-4.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
19. BASHIR Q , Shah N, Parmar S, Wei W, et al
    Feasibility of autologous hematopoietic stem cell transplantation in patients aged >/=70 years with multiple myeloma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. WENDTNER C
    Intensive chemotherapy without stem cell transplant for indolent lymphomas.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
21. GLADSTONE DE , Bolanos-Meade J, Huff CA, Zahurak M, et al
    High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. VIGOUROUX S , Tabrizi R, Melot C, Coiffard J, et al
    Comparable outcome after related or unrelated allogeneic stem cell transplantation following reduced conditioning with fludarabine, busulfan, and antithymocyte globulin.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
23. VAN BESIEN K , Schouten V, Parsad S, Smith S, et al
    Allogeneic Stem Cell Transplantation in Renal failure. Engraftment and Prolonged Survival, but High Incidence of Neurologic Toxicity.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
24. AVIVI I , Fineman R, Haddad N, Katz T, et al
    Fatal Kaposi sarcoma after allogeneic stem cell transplant.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. KIM SJ , Won JH
    B cell homeostasis and the development of chronic graft versus host disease: implications for B cell-depleting therapy.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. WANG ES , Zeidan A, Tan W, Wilding GE, et al
    Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
27. PETERS AC , Duan Q, Russell JA, Duggan P, et al
    Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. SPINA F , Alessandrino PE, Milani R, Bonifazi F, et al
    Allogeneic Stem Cell Transplantation in Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndromes: Impact of Patient Characteristics and Timing of Transplant.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. COHEN KS
    Angiogenesis and multiple myeloma: is there a role for angiogenic biomarkers in the context of autologous stem cell transplant?
    Leuk Lymphoma. 2011;52:1173-5.
    PubMed     Text format     Related articles   
    
    
    
    
30. HA JS , Choi MS
    1q triplication as sole cytogenetic abnormality in myelodysplastic syndrome.
    Leuk Lymphoma. 2011;52:1387-9.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
31. PENNESE E , Vergine C, Matera R, Dargenio M, et al
    Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
32. SACCHI S , Marcheselli R, Lazzaro A, Morabito F, et al
    A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. BASAK GW , Mikala G, Koristek Z, Jaksic O, et al
    Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. FEDELE R , Martino M, Dattola A, Cuzzola M, et al
    Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
35. GERTZ MA
    Stem cell transplant: an effective salvage therapy for multiple myeloma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
36. MURPHY S , Nguyen VH
    Role of gut microbiota in graft-versus-host disease.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. FENK R , Liese V, Neubauer F, Bruns I, et al
    Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantation.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. HERBERT KE , Ritchie DS, Seymour JF
    Strategies to optimize collection of hematopoietic stem cells in patients with mantle cell lymphoma receiving hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate-chemotherapy.
    Leuk Lymphoma. 2011;52:935-7.
    PubMed     Text format     Related articles   
    
    
    
    
39. JUNG HJ , Chen Z, McCarty N
    Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma.
    Leuk Lymphoma. 2011;52:1066-79.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
40. LANE AA , McAfee SL, Kennedy J, Dube C, et al
    High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
41. ENNISHI D , Maeda Y, Fujii N, Kondo E, et al
    Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. SUCAK GT , Aki SZ, Yuzbasioglu B, Akyurek N, et al
    Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. HWANG WY , Piu Koh L, Lim ST, Ching Linn Y, et al
    Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
44. GUILLEM VM , Arbona C, Carlos Hernandez-Boluda J, Jose Terol M, et al
    An XRCC1 polymorphism is associated with the outcome of patients with lymphoma undergoing autologous stem cell transplant.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. HEUTTE N , Haioun C, Feugier P, Coiffier B, et al
    Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. BOHM A , Herrmann H, Mitterbauer-Hohendanner G, Hauswirth AW, et al
    Stable non-transforming minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia after autologous transplantation: origin from neoplastic yet 'pre-leukemic' stem cells?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. DAVIS RE , Westin JR
    Vive la resistance: stem cells in mantle cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
48. HERBERT K , Ritchie DS
    The Goldilocks conundrum: how much granulocyte colony-stimulating factor following autologous stem cell transplant is 'just right'?
    Leuk Lymphoma. 2011;52:548-9.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
49. TACHIBANA T , Numata A, Tanaka M, Motohashi K, et al
    Successful treatment with dasatinib and allogeneic peripheral blood stem cell transplant for imatinib-resistant Philadelphia chromosome-positive acute lymphoblastic leukemia relapsing after bone marrow transplant and donor lymphocyte infusion.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
50. MAINARDI C , D'Amore ES, Pillon M, Toffolutti T, et al
    A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
51. GUNN EJ , Williams JT, Huynh DT, Iannotti MJ, et al
    The natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. HUBEL K , Weingart O, Naumann F, Bohlius J, et al
    Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations.
    Leuk Lymphoma. 2011;52:444-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. WANNESSON L , Luthi F, Zucca E, Rosselet-Christ A, et al
    Pegfilgrastim to accelerate neutrophil engraftment following peripheral blood stem cell transplant and reduce the duration of neutropenia, hospitalization, and use of intravenous antibiotics: a phase II study in multiple myeloma and lymphoma and compa
    Leuk Lymphoma. 2011;52:436-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
54. GOLDSTEIN G , Elhasid R, Bielorai B, Shimoni A, et al
    Adults requiring cord blood transplants but have insufficient cell doses from a single cord blood unit can receive two units with successful engraftment kinetics similar to those of children receiving a single unit.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. HILL BT , Rybicki L, Smith S, Dean R, et al
    Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. FAI CHOW K , Sevilla DW, Colovai AI, Bhagat G, et al
    Hematogones are markedly decreased in chronic myeloid leukemia: multiparametric flow cytometric analysis.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. KERBAUY FR , Rodrigues M, de Souza Santos FP, Sobrinho JN, et al
    Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning.
    Leuk Lymphoma. 2011;52:321-4.
    PubMed     Text format     Related articles   
    
    
    
    
58. DONATO NJ , Peterson LF
    Chronic myeloid leukemia stem cells and developing therapies.
    Leuk Lymphoma. 2011;52 Suppl 1:60-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
59. RYEON LEE S , Lee SY, Nam MH, Park Y, et al
    Successful control of steroid-intolerant Evans' syndrome associated with allogeneic peripheral blood hematopoietic stem cell transplant by rituximab.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
60. CALABRETTA B , Salomoni P
    Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. KERN W , Bacher U, Haferlach C, Schnittger S, et al
    Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cells.
    Leuk Lymphoma. 2011;52:92-100.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
62. KAJIWARA R , Goto H, Tanoshima R, Kato H, et al
    Myeloperoxidase-positive acute leukemia with precursor B cell immunophenotype.
    Leuk Lymphoma. 2010.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: